Fiduciary Trust’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.01M | Buy |
11,137
+475
| +4% | +$39.8K | 0.01% | 416 |
|
|
2026
Q1 | $854K | Sell |
10,662
-15
| -0.1% | -$1.24K | 0.01% | 445 |
|
|
2025
Q4 | $910K | Sell |
10,677
-137
| -1% | -$11.2K | 0.01% | 433 |
|
|
2025
Q3 | $841K | Buy |
10,814
+66
| +0.6% | +$5.16K | 0.01% | 446 |
|
|
2025
Q2 | $841K | Sell |
10,748
-24
| -0.2% | -$1.79K | 0.01% | 438 |
|
|
2025
Q1 | $781K | Sell |
10,772
-4,182
| -28% | -$299K | 0.01% | 444 |
|
|
2024
Q4 | $1.11M | Buy |
14,954
+1,268
| +9% | +$88.7K | 0.01% | 341 |
|
|
2024
Q3 | $903K | Sell |
13,686
-5
| -0% | -$363 | 0.01% | 384 |
|
|
2024
Q2 | $1.26M | Sell |
13,691
-476
| -3% | -$42.2K | 0.02% | 299 |
|
|
2024
Q1 | $1.35M | Sell |
14,167
-225
| -2% | -$18.9K | 0.02% | 293 |
|
|
2023
Q4 | $1.1M | Sell |
14,392
-230
| -2% | -$16K | 0.02% | 318 |
|
|
2023
Q3 | $1.01M | Buy |
14,622
+148
| +1% | +$11.9K | 0.02% | 321 |
|
|
2023
Q2 | $1.37M | Sell |
14,474
-133
| -0.9% | -$11.6K | 0.02% | 286 |
|
|
2023
Q1 | $1.21M | Hold |
14,607
| – | – | 0.02% | 295 |
|
|
2022
Q4 | $1.09M | Sell |
14,607
-3,334
| -19% | -$257K | 0.02% | 321 |
|
|
2022
Q3 | $1.48M | Sell |
17,941
-120
| -0.7% | -$11.5K | 0.03% | 266 |
|
|
2022
Q2 | $1.72M | Sell |
18,061
-1
| -0% | -$104 | 0.04% | 256 |
|
|
2022
Q1 | $2.13M | Buy |
18,062
+50
| +0.3% | +$5.61K | 0.04% | 244 |
|
|
2021
Q4 | $2.33M | Buy |
18,012
+210
| +1% | +$24.5K | 0.04% | 234 |
|
|
2021
Q3 | $2.02M | Buy |
17,802
+307
| +2% | +$35K | 0.04% | 238 |
|
|
2021
Q2 | $1.81M | Buy |
17,495
+2,814
| +19% | +$265K | 0.04% | 258 |
|
|
2021
Q1 | $1.23M | Buy |
14,681
+5
| +0% | +$423 | 0.02% | 302 |
|
|
2020
Q4 | $1.34M | Buy |
14,676
+1,370
| +10% | +$114K | 0.03% | 282 |
|
|
2020
Q3 | $1.06M | Buy |
13,306
+2,613
| +24% | +$204K | 0.03% | 283 |
|
|
2020
Q2 | $739K | Buy |
10,693
+4,666
| +77% | +$332K | 0.02% | 324 |
|
|
2020
Q1 | $379K | Sell |
6,027
-789
| -12% | -$56.9K | 0.01% | 381 |
|
|
2019
Q4 | $530K | Sell |
6,816
-471
| -6% | -$36.8K | 0.01% | 371 |
|
|
2019
Q3 | $534K | Sell |
7,287
-57
| -0.8% | -$4K | 0.01% | 359 |
|
|
2019
Q2 | $453K | Sell |
7,344
-399
| -5% | -$24.1K | 0.01% | 364 |
|
|
2019
Q1 | $494K | Buy |
7,743
+69
| +0.9% | +$3.94K | 0.01% | 350 |
|
|
2018
Q4 | $392K | Hold |
7,674
| – | – | 0.01% | 354 |
|
|
2018
Q3 | $445K | Buy |
7,674
+750
| +11% | +$36.7K | 0.01% | 351 |
|
|
2018
Q2 | $336K | Buy |
6,924
+315
| +5% | +$14.7K | 0.01% | 382 |
|
|
2018
Q1 | $307K | Buy |
+6,609
| New | +$287K | 0.01% | 380 |
|
|
2017
Q3 | – | Sell |
-5,082
| Closed | -$200K | – | 458 |
|
|
2017
Q2 | $200K | Buy |
+5,082
| New | +$185K | 0.01% | 436 |
|
|
2016
Q4 | – | Sell |
-5,082
| Closed | -$204K | – | 442 |
|
|
2016
Q3 | $204K | Buy |
+5,082
| New | +$191K | 0.01% | 428 |
|
Other funds holding EW
Fiduciary Trust's EW Position: Q2 2026 in Review
Fiduciary Trust increased its Edwards Lifesciences (EW) stake by 4.5% in Q2 2026, buying an estimated $39.8K and bringing the position to 11,137 shares worth $1.01M. The position accounts for 0.01% of the portfolio, ranked #416.
Fiduciary Trust first reported a position in EW in Q3 2016 and has held it in 36 quarters since. The position peaked at $2.33M in Q4 2021. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Fiduciary Trust held 11,137 shares of Edwards Lifesciences worth $1.01M as of Q2 2026.
- Fiduciary Trust bought 475 Edwards Lifesciences shares in Q2 2026, an estimated $39.8K.
- Edwards Lifesciences made up 0.01% of Fiduciary Trust's portfolio in Q2 2026, its #416 holding.
- Fiduciary Trust first reported a position in Edwards Lifesciences in Q3 2016 and has held it in 36 quarters since.
- Fiduciary Trust's Edwards Lifesciences position peaked at $2.33M in Q4 2021.
- 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.